Lior Zangi

Cardiovascular Institute of the South — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

32h-index4.6kcitations76works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Interference and Gene Delivery(24), Congenital heart defects research(18), Virus-based gene therapy research(14), Tissue Engineering and Regenerative Medicine(14), Viral Infections and Immunology Research(13)

Publications76 total

Influenza hijacks myeloid cells to inflict type-I interferon-fueled damage in the heart
Immunity·2026
A Systemic Selective Modified mRNA Delivery Platform for Preventing Chemotherapy‐Induced Cardiotoxicity
Advanced Science·2026Open Access
Transient overexpression of hPKM2 in porcine cardiomyocytes prevents heart failure after myocardial infarction
Nature Communications·2025· 1 citedOpen Access
A tumor-selective mRNA system enables precision cancer treatment
Molecular Therapy·2025Open Access
Influenza A virus hijacks monocyte trafficking to damage the heart and impair cardiac function 3069
The Journal of Immunology·2025Open Access
Pyruvate Kinase M2 Role in Cardiovascular Repair
Cells·2025Open Access
An mRNA-based broad-spectrum antiviral inspired by ISG15 deficiency protects against viral infections in vitro and in vivo
Science Translational Medicine·2025· 5 cited
Novel Artificial 5′UTR Increase Modified mRNA Translation When Injected into Mouse Heart
Pharmaceutics·2025Open Access
The Potential of RNA Therapeutics in Treating Cardiovascular Disease
Drugs·2025· 1 cited
Harnessing mRNA technology for ischemic heart disease: a review of regenerative and protective therapies
Cardiology Plus·2025· 2 citedOpen Access
Clinical development of therapeutic mRNA applications
Molecular Therapy·2025· 27 cited
Transcriptional activation of regenerative hematopoiesis via microenvironmental sensing
Nature Immunology·2025· 2 cited
Induced Cytokinesis Generates Highly Proliferative Mononuclear Cardiomyocytes at the Expense of Contractility
Circulation·2025· 5 citedOpen Access
Modified mRNA-Mediated CCN5 Gene Transfer Ameliorates Cardiac Dysfunction and Fibrosis without Adverse Structural Remodeling
International Journal of Molecular Sciences·2024· 7 citedOpen Access
Modified mRNA Mediated CCN5 Gene Transfer Ameliorates Cardiac Dysfunction and Fibrosis without Adverse Structural Remodeling
Preprints.org·2024· 2 citedOpen Access
Lin28a cardiomyocyte-specific modified mRNA translation system induces cardiomyocyte cell division and cardiac repair
Journal of Molecular and Cellular Cardiology·2024· 7 citedOpen Access
ADMINISTRATION OF MODIFIED RNA ENCODING ANTI-MULLERIAN HORMONE (MODRNA-AMH) BEFORE CYCLOPHOSPHAMIDE BRIDGES PROTEIN LOSS UNTIL RESUMPTION OF SECRETION BY A CRITICAL MASS OF GROWING FOLLICLES
Fertility and Sterility·2023· 1 citedOpen Access
Modified mRNA Formulation and Stability for Cardiac and Skeletal Muscle Delivery
Pharmaceutics·2023· 12 citedOpen Access
CCND2 Modified mRNA Activates Cell Cycle of Cardiomyocytes in Hearts With Myocardial Infarction in Mice and Pigs
Circulation Research·2023· 47 citedOpen Access
Abstract P1084: Cardiomyocyte-specific Overexpression Of Ccnd2 Via Modified Mrnafor Remuscularization In Hearts With Myocardial Infarction
Circulation Research·2023
page 1 of 4Next →

Frequent Co-authors

Elena Chepurko(18), Nishat Sultana(12), Keerat Kaur(12), Ajit Magadum(11), Mohammad Tofael Kabir Sharkar(10), Roger J. Hajjar(10), Yoav Hadas(10), Ann Kurian(9), Kenneth R. Chien(7), Yaīr Reisner(7), Magdalena M. Żak(6), Neha Singh(5), Anthony S. Fargnoli(5), Daniela Später(4), Shlomit Reich-Zeliger(4), Esther Bachar-Lustig(4), Elias Shezen(4), Jimeen Yoo(4), Qing Ma(3), William T. Pu(3)